SCHEMBL409162

SCHEMBL409162

CC(=O)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25786 1.00
SCHEMBL28489961 0.97
Acetic Acid SCHEMBL19331447 0.94 FFAR3 (0.44)
SCHEMBL5573998 0.76
SCHEMBL10789600 0.74
SCHEMBL14935695 0.72 KDM4E (0.41)
SCHEMBL8627389 0.71
SCHEMBL618275 0.71
SCHEMBL570228 0.69
SCHEMBL1259537 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024144735-A1 A MICROENCAPSULATED FOOD SUPPLEMENT WITH PROBIOTIC MICROORGANISMS CHIVALRIC REGULUS BIYOTEKNOLOJI ANONIM SIRKETI (TR) 2024-07-04 WO disclosed
CN-109072217-A For treating methylmalonyl-CoA isomerase (MCM) fusion constructs of illness relevant to MCM defect 耶路撒冷希伯来大学伊森姆研究发展有限公司 2018-12-21 CN disclosed
US-20130101569-A1 HAIR GROWTH STIMULANT WESTON ANTHONY R (US) 2013-04-25 US disclosed
CN-103059100-A New peptides useful as dual caspase-2/-6 inhibitor and biological application thereof THERAPTOSIS S A 2013-04-24 CN disclosed
US-8324173-B2 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications CHIESI FARMACEUTICI S.P.A. (IT) 2012-12-04 US disclosed
US-20120021990-A1 PEPTIDES USEFUL AS DUAL CASPASE-2/-6 INHIBITORS AND THEIR BIOLOGICAL APPLICATIONS CHAUVIER DAVID (FR) 2012-01-26 US disclosed
US-20090042805-A1 Peptides Useful As Dual Caspase-2/-6 Inhibitors And Their Biological Applications CHIESI FARMACEUTICI S.P.A. (IT) 2009-02-12 US disclosed
CN-100371336-C Pyrrole derivatives for the treatment of cytokine mediated diseases SANKYO CO (JP) 2008-02-27 CN disclosed
EP-1817328-A2 NEW PEPTIDES USEFUL AS DUAL CASPASE-2/-6 INHIBITORS AND THEIR BIOLOGICAL APPLICATIONS Theraptosis S.A. (FR) 2007-08-15 EP disclosed
WO-2006056487-A2 PEPTIDES USEFUL AS DUAL CASPASE-2/-6 INHIBITORS AND THEIR BIOLOGICAL APPLICATIONS THERAPTOSIS S.A. (FR) 2006-06-01 WO disclosed
US-20060110789-A1 Methods to mediate polyketide synthase module effectiveness NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-05-25 US disclosed
US-7001748-B2 Methods of making polyketides using hybrid polyketide synthases THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2006-02-21 US disclosed
CN-1553911-A pyrrole derivatives, their preparation and their therapeutic use ������������ʽ���� 2004-12-08 CN disclosed
WO-2003076581-A2 METHODS TO MEDIATE POLYKETIDE SYNTHASE MODULE EFFECTIVENESS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2003-09-18 WO disclosed
US-20030068676-A1 Methods to mediate polyketide synthase module effectiveness NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-04-10 US disclosed